Efficacy and Safety Study of StemEx®, to Treat Subjects With High Risk Hematologic Malignancies, Following Myeloablative Therapy
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Agha Mounzer, MD
University of Pittsburgh Cancer Institute/UPMC Cancer Centers
Principal Investigator - Alberto Bosi, MD
Ospedale di Careggi BMT Unit Department of Haematology
Principal Investigator - Celia Grosskreutz, MD
Icahn School of Medicine at Mount Sinai
Principal Investigator - Christelle Ferra, MD
Germans Trias i Pujol Hospital
Principal Investigator - Cristina Arbona, MD
Hospital Clínico Universitario de Valencia
Principal Investigator - Dr. Cristina Diaz de Heredia, MD
Hospital Universitario Vall d´Hebrón
Principal Investigator - Dr. Mi Kwon, MD
Hospital General Universitario Gregorio Marañon
Principal Investigator - Dr. Pere Barba, MD
Hospital Universitario Vall d´Hebrón
Principal Investigator - Entezam Sahovic, MD
The Western Pennsylvania Hospital
Principal Investigator - Guillermo Sanz, MD
Hospital Universitario La Fe
Principal Investigator - Igor B. Resnick, MD, PhD
Department of Bone Marrow Transplantation And Cancer Immunotherapy Hebrew University Hospital Ein-Karem, Jerusalem
Principal Investigator - Jorge Sierra, MD
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Principal Investigator - Ka Wah Chan, MD
Texas Transplant Institute
Principal Investigator - Mary Territo, MD
UCLA Oncology Center
Principal Investigator - Patrick Stiff, MD
Loyola University Cardinal Bernardin Cancer Center
Principal InvestigatorKOL profile → - Prof. Franco Locatelli, MD
Ospedale Pedriatrico Bambino Gesù
Principal Investigator - Prof. Mary J Laughlin, MD
Hematopoietic Stem Cell Transplant Program, University of Virginia
Principal Investigator - Roger Giller, MD
The Children's Hospital, B115, University of Colorado Health Sciences Center
Principal Investigator - Ronit Yerushalmi, MD
Chaim Sheba Medical Center
Principal Investigator - Scott D Rowley, MD
The Cancer Center at Hackensack University Medical Center
Principal Investigator - Sonali Chaudhury, MD
Northwestern University School of Medicine, Stem Cell Transplant Program, Children's Memorial Hospital
Principal Investigator - Steven Neudorf, MD
Children's Hospital of Orange County
Principal Investigator - Tsila Zuckerman, MD
Rambam Health Care Campus
Principal Investigator - William Arcese, MD
Universita di Roma Tor Vergata
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
30 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Szent Laszlo & Szent Istvan Hospital
Budapest, Hungary
- Hebrew University Hospital Ein-Karem, Department of Bone Marrow Transplantation and Cancer Immunotherapy
Jerusalem, Israel
- Rambam Medical Center
PO Box 9602, Haifa, Israel
- Chaim Sheba Medical Center
Tel Litwinsky, Israel
- Ospedale Pedriatrico Bambino Gesù
Roma, Italy
- Universita Di Roma Tor Vergata
Via Oxford 81, Roma, Italy
- Ospedale Di Careggi Bmt Unit Department of Haematology
Viale Morgagni, Florence, Italy
- Hospital Clínico Universitario de Valencia
Avda. Blasco Ibañez, 17, Valencia, Valencia, Spain
- Hospital Universitario la Fe
Av Campanar 21, Valencia, Spain
- Hospital de la Santa Creu I Sant Pau
C/ Sant Antoni Maria Claret, Barselona, Spain
- Hospital Germans Trias I Pujol
Carretera de Canyet S/n, Badalona, Spain
- Hospital General Universitario Gregorio Marañón
Doctor Esquerdo 46 , Madrid, Spain
- Hospital Universitario Vall D´hebrón
Passeig de La Vall d´Hebrón 119-129, Barcelona, Spain
- Hospital Universitario Vall D´hebrón (pediatrics)
Passeig de La Vall d´Hebrón 119-129, Barcelona, Spain
- Ucla'S Jonsson Comprehensive Cancer Center
Los Angeles, California, United States
- Children'S Hospital of Orange County
Orange, California, United States
- the Children'S Hospital, B115, University of Colorado Health Sciences Center
Aurora, Colorado, United States
- Northwestern University School of Medicine, Stem Cell Transplant Program, Children'S Memorial Hospital
Chicago, Illinois, United States
- Cardinal Bernardin Cancer Center, Loyola University Stritch School of Medicine
Maywood, Illinois, United States
- the Cancer Center at Hackensack University Medical Center
Hackensack, New Jersey, United States
- Cornell University, Joan & Sanford I. Weill Medical College
New York, New York, United States
- Steven and Alexandra Cohen Children'S Medical Center of New York
New York, New York, United States
- Mount Sinai Medical Center
One Gustave L Levy Place, BOX 1410, New York, New York, United States
- Case Western Reserve University
Cleveland, Ohio, United States
- the Western Pennsylvania Hospital
Pittsburgh, Pennsylvania, United States
- University of Pittsburgh Cancer Institute/upmc Cancer Centers
Pittsburgh, Pennsylvania, United States
- Texas Transplant Institute
San Antonio, Texas, United States
- University of Virginia, Hematopoietic Stem Cell Transplant Program
West Complex 1300 Jefferson Park Av, Charlottesville, Virginia, United States
- Medical College of Wisconsin Division of Neoplastic Diseases and Related Disorders
Milwaukee, Wisconsin, United States
- Medical College of Wisconsin Pediatric Blood and Marrow Transplant Program
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2007
- Primary completion
- 28 Feb 2013
- Completion
- 30 Jun 2015
- Last update posted
- 10 Jul 2015
- Registered enrollment
- 101
- Registry id
- NCT00469729
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.